Robin DiFrancesco

1.2k total citations
53 papers, 968 citations indexed

About

Robin DiFrancesco is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robin DiFrancesco has authored 53 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 20 papers in Virology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robin DiFrancesco's work include HIV/AIDS drug development and treatment (42 papers), HIV Research and Treatment (20 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Robin DiFrancesco is often cited by papers focused on HIV/AIDS drug development and treatment (42 papers), HIV Research and Treatment (20 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Robin DiFrancesco collaborates with scholars based in United States, Zimbabwe and Qatar. Robin DiFrancesco's co-authors include Gene D. Morse, Valerie Frerichs, Diane T. Holland, Robert DiCenzo, James D. Connor, Kathleen M. Tornatore, Qing Ma, Jennifer J. Griggs, Suzanne Siminski and Richard C. Reichman and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and AIDS.

In The Last Decade

Robin DiFrancesco

51 papers receiving 933 citations

Peers

Robin DiFrancesco

VIROL

PPCH

EPIDE

Robert DiCenzo United States

Michael Lamson United States

Charles la Porte Canada

Gary J. Muirhead United Kingdom

C.P.W.G.M. Verwey-van Wissen Netherlands

John P. Sabo United States

Thomas R. MacGregor United States

Cornelis H.W. Koks Netherlands

Joseph E. Rower United States

P. L. Meenhorst Netherlands

Robert DiCenzo United States

Robin DiFrancesco

357 ×0.7

195 ×0.7

VIROL

182 ×0.9

PPCH

121 ×0.9

EPIDE

85 ×0.7

Citations per year, relative to Robin DiFrancesco Robin DiFrancesco (= 1×) peers Robert DiCenzo

Countries citing papers authored by Robin DiFrancesco

Since Specialization

Citations

This map shows the geographic impact of Robin DiFrancesco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin DiFrancesco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin DiFrancesco more than expected).

Fields of papers citing papers by Robin DiFrancesco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin DiFrancesco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin DiFrancesco. The network helps show where Robin DiFrancesco may publish in the future.

Co-authorship network of co-authors of Robin DiFrancesco

This figure shows the co-authorship network connecting the top 25 collaborators of Robin DiFrancesco. A scholar is included among the top collaborators of Robin DiFrancesco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin DiFrancesco. Robin DiFrancesco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Qing, Raymond Cha, Kevin Zemaitis, et al.. (2025). LC-MS/MS method for quantifying the HIV-1 broadly neutralizing antibody PGT 121.414.LS in human serum. Journal of Chromatography B. 1266. 124774–124774.

Maponga, Charles C., et al.. (2021). Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained setting. Cost Effectiveness and Resource Allocation. 19(1). 73–73. 3 indexed citations

Ocque, Andrew J., et al.. (2019). Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited setting. African Journal of Laboratory Medicine. 8(1). 880–880. 2 indexed citations

Ocque, Andrew J., et al.. (2019). Development and validation of an assay to measure cannabidiol and Δ9-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS/MS. Journal of Chromatography B. 1112. 56–60. 17 indexed citations

Ocque, Andrew J., et al.. (2017). Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates. Journal of Chromatography B. 1052. 103–109. 14 indexed citations

Kiser, Jennifer J., Darlene Lu, Susan L. Rosenkranz, et al.. (2017). Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s. Drugs in R&D. 17(4). 557–567. 3 indexed citations

Luque, Amneris E., Barry S. Zingman, Margaret A. Fischl, et al.. (2016). Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders. Current Vascular Pharmacology. 14(3). 280–287. 8 indexed citations

DiFrancesco, Robin, et al.. (2013). Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research. Clinical Pharmacology & Therapeutics. 93(6). 479–482. 50 indexed citations

Tornatore, Kathleen M., Kiran Dole, Robin DiFrancesco, et al.. (2011). Mycophenolic Acid Pharmacokinetics During Maintenance Immunosuppression in African American and Caucasian Renal Transplant Recipients. The Journal of Clinical Pharmacology. 51(8). 1213–1222. 22 indexed citations

10.

Ma, Qing, Barry S. Zingman, Amneris E. Luque, et al.. (2011). Therapeutic Drug Monitoring of Protease Inhibitors and Efavirenz in HIV-Infected Individuals With Active Substance-Related Disorders. Therapeutic Drug Monitoring. 33(3). 309–314. 3 indexed citations

11.

Demeter, Lisa M., Hongyu Jiang, Aprateem Mukherjee, et al.. (2009). A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients. AIDS. 23(3). 357–368. 14 indexed citations

12.

Demeter, Lisa M., Robin DiFrancesco, Hongyu Jiang, et al.. (2008). The Design and Implementation of A5146, a Prospective Trial Assessing the Utility of Therapeutic Drug Monitoring Using an Inhibitory Quotient in Antiretroviral-Experienced HIV-Infected Patients. HIV Clinical Trials. 9(1). 61–72. 5 indexed citations

13.

Ma, Qing, Barry S. Zingman, Richard C. Reichman, et al.. (2007). Assessing the Impact of Substance use and Hepatitis Coinfection on Atazanavir and Lopinavir Trough Concentrations in HIV-Infected Patients During Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 29(5). 560–565. 13 indexed citations

14.

DiFrancesco, Robin, Margaret A. Fischl, Barry S. Zingman, et al.. (2007). Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users. Journal of Pharmaceutical and Biomedical Analysis. 44(1). 188–195. 4 indexed citations

15.

DiFrancesco, Robin, Barry S. Zingman, Richard C. Reichman, et al.. (2007). Integration of Atazanavir into an Existing Liquid Chromatography UV Method for Protease Inhibitors: Validation and Application. Therapeutic Drug Monitoring. 29(1). 103–109. 19 indexed citations

16.

DiFrancesco, Robin, et al.. (2007). Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry. Journal of Chromatography B. 852(1-2). 545–553. 49 indexed citations

17.

DiFrancesco, Robin, et al.. (2006). Tutorial Reduces Protocol Deviations in Multicenter ACTG Trials with Pharmacology Endpoints. HIV Clinical Trials. 7(4). 203–209. 6 indexed citations

18.

Smith, Patrick F., Abayomi Ogundele, Robin DiFrancesco, et al.. (2006). Inhibition of Atazanavir Oral Absorption by Lansoprazole Gastric Acid Suppression in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(3). 341–346. 67 indexed citations

19.

DiFrancesco, Robin, et al.. (2006). Determination of Tipranavir in Human Plasma by Reverse Phase Liquid Chromatography With UV Detection Using Photodiode Array. Therapeutic Drug Monitoring. 28(4). 512–516. 7 indexed citations

20.

Tornatore, Kathleen M., Kevin W. Garey, Brian M. Murray, et al.. (2001). Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clinical Transplantation. 15(5). 297–308. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact